The purpose of this legislation, known as the Medical Innovation Acceleration Act of 2025, is to simplify the regulatory process for certain medical devices. Specifically, it aims to exempt non-invasive diagnostic devices from being classified as medical devices under the Federal Food, Drug, and Cosmetic Act. This change is intended to encourage innovation and development in the field of medical diagnostics. Key provisions of the legislation include a clear definition of what constitutes a non-invasive diagnostic device.